Cornell University's Nicotine Vaccine Curbs the Habit for Good

By: Sarah Moore - Published: • References: & gizmag
It has been said that quitting smoking can be more difficult than trying to quit heroin, and if the Nicotine Vaccine developed by researchers at Cornell University's Medical College fulfills its promise -- life-long smokers will be able to curb their addition for good.

While thus far it has only been tested on mice, the results have been promising. The vaccine works in the kidneys, pumping the nicotine out of one's body before it has the chance to make it to one's brain and provide that addictive rush that gets people hooked.

The effects of a single dose can last for a lifetime and has also been reported to prevent non-smokers from ever becoming addicted in the first place. Stats for Anti-Smoking Solutions Trending: Older & Mild
Traction: 510 clicks in 142 w
Interest: 0.6 minutes
Concept: Nicotine Vaccine
Related: 75 examples / 58 photos
Segment: Neutral, 18-55+
Comparison Set: 28 similar articles, including: surreal femme fatale paintings, 70 shocking anti-smoking campaigns, and 60 pro-cigarette photoshoots.